NEW PLATFORMS AND PRODUCTS

Venkor Pharma develops, innovative challenging platforms and products in USA and Chantilly Biopharma P Ltd, Hyderabad, India.

In addition to multiple technology platforms and products library, Venkor has developed new Proprietary Drug delivery system for Fixed-Dose Combination (FDC) products. Modified release FD Combination products for high dose actives in combination with small dose actives to treat multiple therapies IN RX, OTC, DIETARY SUPPLEMENTS AND ORAL CARE.

Therapeutic categories include

  • • Diabetic
  • • CNS
  • • Cardiovascular
  • • Anti-infectives
  • • Pain
  • • Respiratory
  • • Oral care - anti-virus and anti-bacterial
  • Patents Pending.

Venkor Specializes in

  • • Microencapsulation and taste masking
  • • Nano particles
  • • Rapid-Melt – Tablets,
  • • Chew-Melters
  • • Flash-Melt beads

DETAILS CAN BE OBTAINED VIA BUSINESS DEVELOPMENT CONTACT. VENKOR WOULD LIKE TO PARTNER WITH PHARMA COMPANIES TO ADVANCE LAUNCHING PRODUCTS.

Business Development contact

Subraman Cherukuri
Email: src43y@venkorsp.com | src43y@ymail.com
Tel: 703-932-3840

TOP